Deal Summary

Inhibrx Biosciences

$500,000,000

Expanded facility

Oxford Finance

Deal Notes:

To support working capital needs

Industry:

Biopharmaceuticals

Role:

Lender

Event:

Recapitalization

Recent Deal Announcements